Advertisement

Journal of Genetic Counseling

, Volume 24, Issue 3, pp 381–387 | Cite as

Creation of a National, At-home Model for Ashkenazi Jewish Carrier Screening

  • Karen Arnovitz GrinzaidEmail author
  • Patricia Zartman Page
  • Jessica Johnson Denton
  • Jessica Ginsberg
PROFESSIONAL ISSUES

Abstract

Ethnicity-based carrier screening for the Ashkenazi Jewish population has been available and encouraged by advocacy and community groups since the early 1970’s. Both the American College of Medical Genetics and the American Congress of Obstetricians and Gynecologists recommend carrier screening for this population (Obstetrics and Gynecology, 114(4), 950–953, 2009; Genetics in Medicine, 10(1), 55–56, 2008). While many physicians inquire about ethnic background and offer appropriate carrier screening, studies show that a gap remains in implementing recommendations (Genetic testing and molecular biomarkers, 2011). In addition, education and outreach efforts targeting Jewish communities have had limited success in reaching this at-risk population. Despite efforts by the medical and Jewish communities, many Jews of reproductive age are not aware of screening, and remain at risk for having children with preventable diseases. Reaching this population, preferably pre-conception, and facilitating access to screening is critically important. To address this need, genetic counselors at Emory University developed JScreen, a national Jewish genetic disease screening program. The program includes a national marketing and PR campaign, online education, at-home saliva-based screening, post-test genetic counseling via telephone or secure video conferencing, and referrals for face-to-face genetic counseling as needed. Our goals are to create a successful education and screening program for this population and to develop a model that could potentially be used for other at-risk populations.

Keywords

Jewish Genetic Carrier Screening Reproductive 

Notes

Acknowledgments

Funding for the JScreen project was provided through a grant from The Marcus Foundation. We are grateful to Dr. Carlo Castellani for granting us permission to adapt knowledge questions from his work for our purposes.

Conflict of Interest

Authors Karen Arnovitz Grinzaid, Patricia Zartman Page, Jessica L. Johnson, and Jessica Ginsburg declare that they have no conflict of interest.

Animal and Human Studies

No animal or human studies were carried out by the authors for this article.

References

  1. Castellani, C., Perobelli, S., Bianchi, V., Seia, M., Melotti, P., Zanolla, L., & Lalatta, F. (2011). An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. American Journal of Medical Genetics Part A, 155(4), 778–785. doi: 10.1002/ajmg.a.33870.CrossRefGoogle Scholar
  2. Chen, L.-S., & Goodson, P. (2007). Factors affecting decisions to accept or decline cystic fibrosis carrier testing/screening: a theory-guided systematic review. Genetics in Medicine, 9(7), 442–450.CrossRefGoogle Scholar
  3. Consortium, Jewish Genetic Disease.). Jewish Genetic Diseases. Retrieved 11/20/2013, from http://www.jewishgeneticdiseases.org/jewish-genetic-diseases/.
  4. Darcy, D, Tian, L., Taylor, J., & Schrijver, I. (2011). Cystic fibrosis .Carrier screening in obstetric clinical practice: Knowledge, practices, and barriers, a decade after publication of screening guidelines. Genetic testing and molecular biomarkers. Google Scholar
  5. Genetics, ACOG Committee Genetics on. (2009). ACOG committee opinion No. 442: preconception and prenatal carrier screening for genetic diseases in individuals of eastern European Jewish descent. Obstetrics and Gynecology, 114(4), 950–953.CrossRefGoogle Scholar
  6. Gross, S. J., Pletcher, B. A., & Monoghan, K. G. (2008). Carrier screening in individuals of Ashkenazi Jewish descent. Genetics in Medicine, 10(1), 55–56.CrossRefGoogle Scholar
  7. Hoffman, J. D., Greger, V., Strovel, E. T., Blitzer, M. G., Umbarger, M. A., Kennedy, C., & Towne, C. (2013). Next-generation DNA sequencing of HEXA: a step in the right direction for carrier screening. Molecular Genetics & Genomic Medicine, 1(4), 260–268. doi: 10.1002/mgg3.37.CrossRefGoogle Scholar
  8. Janssens, S., Paepe, A., & Borry, P. (2012). Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature. Journal of Community Genetics, 1–17. doi:  10.1007/s12687-012-0131-z.CrossRefGoogle Scholar
  9. Kaback, M. M. (2000). Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. European Journal of Pediatrics, 159(Suppl 3), S192–S195.CrossRefGoogle Scholar
  10. Klitzman, R., Chung, W., Marder, K., Shanmugham, A., Chin, L. J., Stark, M., & Appelbaum, P. S. (2013). Attitudes and practices among internists concerning genetic testing. Journal of Genetic Counseling, 22(1), 90–100. doi: 10.1007/s10897-012-9504-z.CrossRefGoogle Scholar
  11. Klugman, S., & Gross, S. J. (2010). Ashkenazi Jewish screening in the twenty-first century. Obstetrics and Gynecology Clinics of North America, 37(1), 37–46. doi: 10.1016/j.ogc.2010.01.001.CrossRefGoogle Scholar
  12. Schneider, A., Nakagawa, S., Keep, R., Dorsainville, D., Charrow, J., Aleck, K., & Gross, S. (2009). Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing. American Journal of Medical Genetics Part A, 149A(11), 2444–2447. doi: 10.1002/ajmg.a.33085.CrossRefGoogle Scholar
  13. The Pew Research Center's Internet & American Life Project. (2013). Retrieved 12/10/2013, from http://www.pewinternet.org/Commentary/2011/November/Pew-Internet-Health.aspx.

Copyright information

© National Society of Genetic Counselors, Inc. 2014

Authors and Affiliations

  • Karen Arnovitz Grinzaid
    • 1
    Email author
  • Patricia Zartman Page
    • 1
  • Jessica Johnson Denton
    • 1
  • Jessica Ginsberg
    • 1
  1. 1.Department of Human GeneticsEmory UniversityAtlantaUSA

Personalised recommendations